• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从影像学到胶质母细胞瘤生物学:局部复发问题的新临床肿瘤学视角。

From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.

机构信息

Radiotherapy Unit, 1st Department of Radiology, Medical School, Aretaieion University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Radiotherapy Unit, 2nd Department of Radiology, Medical School, ATTIKON University Hospital, National and Kapodistrian University of Athens, Rimini 1, 12462, Chaidari, Greece.

出版信息

Clin Transl Oncol. 2018 Aug;20(8):989-1003. doi: 10.1007/s12094-018-1831-6. Epub 2018 Jan 15.

DOI:10.1007/s12094-018-1831-6
PMID:29335830
Abstract

GBM is one of the most common and aggressive brain tumors. Surgery and adjuvant chemoradiation have succeeded in providing a survival benefit. Although most patients will eventually experience local recurrence, the means to fight recurrence are limited and prognosis remains poor. In a disease where local control remains the major challenge, few trials have addressed the efficacy of local treatments, either surgery or radiation therapy. The present article reviews recent advances in the biology, imaging and biomarker science of GBM as well as the current treatment status of GBM, providing new perspectives to the problem of local recurrence.

摘要

GBM 是最常见和侵袭性的脑肿瘤之一。手术和辅助放化疗已成功提供生存获益。尽管大多数患者最终会经历局部复发,但治疗复发的手段有限,预后仍然较差。在局部控制仍然是主要挑战的疾病中,很少有试验研究局部治疗(手术或放疗)的疗效。本文综述了 GBM 的生物学、影像学和生物标志物科学的最新进展以及 GBM 的当前治疗状况,为局部复发问题提供了新的视角。

相似文献

1
From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.从影像学到胶质母细胞瘤生物学:局部复发问题的新临床肿瘤学视角。
Clin Transl Oncol. 2018 Aug;20(8):989-1003. doi: 10.1007/s12094-018-1831-6. Epub 2018 Jan 15.
2
Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.复发性多形性胶质母细胞瘤再次手术及挽救性治疗的益处:来自单一机构的结果。
J Neurooncol. 2017 May;132(3):419-426. doi: 10.1007/s11060-017-2383-2. Epub 2017 Apr 3.
3
Glioblastoma multiforme: evidence-based approach to therapy.多形性胶质母细胞瘤:基于证据的治疗方法。
Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S23-7. doi: 10.1586/14737140.7.12s.S23.
4
Treating recurrent glioblastoma: an update.复发性胶质母细胞瘤的治疗:最新进展
CNS Oncol. 2015;4(2):91-104. doi: 10.2217/cns.14.55.
5
Tissue Hypoxia and Alterations in Microvascular Architecture Predict Glioblastoma Recurrence in Humans.组织缺氧和微血管结构改变可预测人类胶质母细胞瘤的复发。
Clin Cancer Res. 2021 Mar 15;27(6):1641-1649. doi: 10.1158/1078-0432.CCR-20-3580. Epub 2020 Dec 8.
6
Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.复发性胶质母细胞瘤全切除术后再照射:复发的空间模式及文献综述作为靶区定义的基础
Strahlenther Onkol. 2017 Nov;193(11):897-909. doi: 10.1007/s00066-017-1161-6. Epub 2017 Jun 14.
7
Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease.多形性胶质母细胞瘤所致的脑膜脊髓转移:疾病少见表现的治疗和处理。
J Neurosurg Spine. 2012 Nov;17(5):438-48. doi: 10.3171/2012.7.SPINE12212. Epub 2012 Sep 7.
8
Recurrent glioblastoma multiforme: a review of natural history and management options.复发性多形性胶质母细胞瘤:自然病程与治疗选择综述
Neurosurg Focus. 2006 Apr 15;20(4):E5. doi: 10.3171/foc.2006.20.4.2.
9
Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).用于胶质母细胞瘤的NovoTTF-100A™系统的临床实践经验:患者登记数据集(PRiDe)
Semin Oncol. 2014 Oct;41 Suppl 6:S4-S13. doi: 10.1053/j.seminoncol.2014.09.010. Epub 2014 Sep 16.
10
Adult Glioblastoma.成人胶质母细胞瘤。
J Clin Oncol. 2017 Jul 20;35(21):2402-2409. doi: 10.1200/JCO.2017.73.0119. Epub 2017 Jun 22.

引用本文的文献

1
Advanced Bioinformatics Analysis and Genetic Technologies for Targeting Autophagy in Glioblastoma Multiforme.高级生物信息分析和遗传技术在多形性胶质母细胞瘤自噬靶向治疗中的应用。
Cells. 2023 Mar 15;12(6):897. doi: 10.3390/cells12060897.
2
IL-10 in glioma.白介素-10 在神经胶质瘤中的作用。
Br J Cancer. 2021 Nov;125(11):1466-1476. doi: 10.1038/s41416-021-01515-6. Epub 2021 Aug 4.
3
Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs.使用离子通道药物抑制辐射和替莫唑胺诱导的胶质母细胞瘤侵袭伪足活性。

本文引用的文献

1
Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.基于数学模型的胶质母细胞瘤临床意义:批判性综述。
J Neurooncol. 2018 Jan;136(1):1-11. doi: 10.1007/s11060-017-2650-2. Epub 2017 Oct 28.
2
White matter tractography for neurosurgical planning: A topography-based review of the current state of the art.用于神经外科手术规划的白质纤维束成像:基于地形学的当前技术水平综述。
Neuroimage Clin. 2017 Jun 15;15:659-672. doi: 10.1016/j.nicl.2017.06.011. eCollection 2017.
3
Reoperation for Recurrent Glioblastoma Multiforme.
Cancers (Basel). 2020 Oct 8;12(10):2888. doi: 10.3390/cancers12102888.
4
Glioblastoma multiforme that unusually present with radiographic dural tails: Questioning the diagnostic paradigm with a rare case report.多形性胶质母细胞瘤罕见地出现影像学硬脑膜尾征:通过一例罕见病例报告对诊断范式提出质疑。
Radiol Case Rep. 2020 May 8;15(7):1087-1090. doi: 10.1016/j.radcr.2020.05.007. eCollection 2020 Jul.
5
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology.当前和未来的影像学方法评估神经肿瘤免疫治疗反应。
Theranostics. 2019 Jul 9;9(17):5085-5104. doi: 10.7150/thno.34415. eCollection 2019.
复发性多形性胶质母细胞瘤的再次手术
Neurosurg Clin N Am. 2017 Jul;28(3):407-428. doi: 10.1016/j.nec.2017.02.007.
4
The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme.表皮生长因子受体 III 突变作为多形性胶质母细胞瘤免疫治疗的靶点。
Eur J Pharmacol. 2017 Sep 5;810:70-82. doi: 10.1016/j.ejphar.2017.05.064. Epub 2017 Jun 2.
5
Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.美国食品药品监督管理局批准替莫唑胺联合放疗和贝伐单抗后胶质母细胞瘤患者的生存获益:一项基于人群的研究。
Oncotarget. 2017 Jul 4;8(27):44015-44031. doi: 10.18632/oncotarget.17054.
6
Glioma Subclassifications and Their Clinical Significance.胶质瘤的分类及其临床意义。
Neurotherapeutics. 2017 Apr;14(2):284-297. doi: 10.1007/s13311-017-0519-x.
7
Prospect of rindopepimut in the treatment of glioblastoma.rindopepimut治疗胶质母细胞瘤的前景
Expert Opin Biol Ther. 2017 Apr;17(4):507-513. doi: 10.1080/14712598.2017.1299705. Epub 2017 Mar 5.
8
New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.胶质瘤的新分子研究考量:异柠檬酸脱氢酶(IDH)、α-地中海贫血/智力发育障碍综合征X连锁基因(ATRX)、B-Raf原癌基因(BRAF)、端粒酶逆转录酶(TERT)、组蛋白H3第27位赖氨酸甲基化(H3 K27M)
Curr Neurol Neurosci Rep. 2017 Feb;17(2):19. doi: 10.1007/s11910-017-0722-5.
9
The role of radiation in treating glioblastoma: here to stay.放疗在胶质母细胞瘤治疗中的作用:不可或缺。
J Neurooncol. 2017 Sep;134(3):479-485. doi: 10.1007/s11060-016-2348-x. Epub 2017 Mar 7.
10
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov.胶质母细胞瘤介入性临床试验的现状与展望——基于ClinicalTrials.gov的分析
Radiat Oncol. 2017 Jan 3;12(1):1. doi: 10.1186/s13014-016-0740-5.